|3Jun 25, 6:47 PM ET

KENSEY NASH CORP 3

3 · KENSEY NASH CORP · Filed Jun 25, 2012

Insider Transaction Report

Form 3
Period: 2012-06-19
Holdings
  • Common Stock

    (indirect: See Explanation of Responses)
    7,107,255
Footnotes (1)
  • [F1]The Reporting Person is filing this Form 3 on behalf of itself and on behalf of Biomedical Acquisition Corporation ("Biomedical"), formerly a Delaware corporation and an indirect wholly owned subsidiary of the Reporting Person, with principal executive offices located at 45 Waterview Blvd., Parsippany, NJ 07054. The shares of common stock to which this Form 3 relates were acquired by Biomedical in a tender offer for all outstanding shares of common stock of Kensey Nash Corporation, upon the terms and subject to the conditions set forth in the Offer to Purchase dated May 21, 2012, which was annexed to and filed with the Schedule TO filed by the Reporting Person with the Securities and Exchange Commission on May 21, 2012.

Documents

1 file
  • 3
    a3.xmlPrimary

    3